 Angus Toland
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningioma | 2 | 2021 | 91 | 1.280 |
Why?
| | Meningeal Neoplasms | 2 | 2021 | 100 | 1.260 |
Why?
| | Brain Neoplasms | 6 | 2025 | 1238 | 1.190 |
Why?
| | Spinal Cord Neoplasms | 3 | 2023 | 37 | 0.920 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2024 | 44 | 0.890 |
Why?
| | Glioma | 2 | 2024 | 395 | 0.800 |
Why?
| | Chondrosarcoma | 1 | 2022 | 16 | 0.770 |
Why?
| | Fibroma | 1 | 2022 | 21 | 0.760 |
Why?
| | Osteosarcoma | 1 | 2022 | 74 | 0.730 |
Why?
| | Mutation | 6 | 2025 | 3958 | 0.710 |
Why?
| | Biomarkers, Tumor | 4 | 2025 | 1276 | 0.650 |
Why?
| | Bone Neoplasms | 1 | 2022 | 247 | 0.630 |
Why?
| | Small Cell Lung Carcinoma | 2 | 2025 | 96 | 0.410 |
Why?
| | Astrocytoma | 2 | 2024 | 128 | 0.380 |
Why?
| | Lung Neoplasms | 3 | 2025 | 2526 | 0.260 |
Why?
| | Submandibular Gland | 1 | 2025 | 20 | 0.240 |
Why?
| | Nose Neoplasms | 1 | 2025 | 25 | 0.230 |
Why?
| | Carcinosarcoma | 1 | 2025 | 21 | 0.230 |
Why?
| | Interleukin-5 | 1 | 2025 | 44 | 0.230 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 26 | 0.230 |
Why?
| | Perivascular Epithelioid Cell Neoplasms | 1 | 2024 | 2 | 0.230 |
Why?
| | Lymphoma, B-Cell, Marginal Zone | 1 | 2024 | 13 | 0.220 |
Why?
| | Adrenoleukodystrophy | 1 | 2024 | 9 | 0.220 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 56 | 0.220 |
Why?
| | Proof of Concept Study | 1 | 2024 | 78 | 0.220 |
Why?
| | Teratoma | 1 | 2025 | 114 | 0.220 |
Why?
| | Anus Neoplasms | 1 | 2024 | 33 | 0.210 |
Why?
| | Fatal Outcome | 1 | 2024 | 303 | 0.210 |
Why?
| | DNA Copy Number Variations | 2 | 2025 | 182 | 0.210 |
Why?
| | Cauda Equina | 1 | 2023 | 6 | 0.210 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2023 | 42 | 0.200 |
Why?
| | Lymphoproliferative Disorders | 1 | 2023 | 57 | 0.200 |
Why?
| | Carcinoma, Small Cell | 1 | 2023 | 172 | 0.200 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 77 | 0.200 |
Why?
| | Polyomavirus | 1 | 2022 | 12 | 0.200 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 123 | 0.190 |
Why?
| | Atlases as Topic | 1 | 2022 | 10 | 0.190 |
Why?
| | Polyomavirus Infections | 1 | 2022 | 31 | 0.190 |
Why?
| | Humans | 27 | 2025 | 137585 | 0.190 |
Why?
| | Nonlinear Optical Microscopy | 1 | 2022 | 1 | 0.190 |
Why?
| | Cells | 1 | 2022 | 25 | 0.190 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 217 | 0.190 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2024 | 249 | 0.190 |
Why?
| | Gangliosides | 1 | 2022 | 20 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2023 | 98 | 0.190 |
Why?
| | Central Nervous System Neoplasms | 1 | 2024 | 156 | 0.180 |
Why?
| | Peripheral Nerves | 1 | 2022 | 65 | 0.180 |
Why?
| | Organ Specificity | 1 | 2022 | 305 | 0.180 |
Why?
| | Immunohistochemistry | 2 | 2024 | 1738 | 0.180 |
Why?
| | Brain Stem Neoplasms | 1 | 2022 | 83 | 0.180 |
Why?
| | Ependymoma | 1 | 2023 | 165 | 0.180 |
Why?
| | Neural Stem Cells | 1 | 2023 | 156 | 0.180 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2021 | 48 | 0.180 |
Why?
| | Sarcoma, Clear Cell | 1 | 2020 | 10 | 0.170 |
Why?
| | RNA Splicing | 1 | 2022 | 269 | 0.170 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2021 | 126 | 0.170 |
Why?
| | Papillomavirus Infections | 1 | 2024 | 325 | 0.160 |
Why?
| | Disease Susceptibility | 1 | 2022 | 347 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 804 | 0.160 |
Why?
| | Neoplasm Grading | 1 | 2020 | 307 | 0.160 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 313 | 0.150 |
Why?
| | Neurons | 2 | 2025 | 1590 | 0.150 |
Why?
| | Cholecystitis | 1 | 2019 | 24 | 0.150 |
Why?
| | Transcriptome | 2 | 2022 | 971 | 0.150 |
Why?
| | Tumor Suppressor Proteins | 1 | 2021 | 327 | 0.150 |
Why?
| | Hematologic Diseases | 1 | 2019 | 62 | 0.150 |
Why?
| | Needles | 1 | 2019 | 59 | 0.150 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 327 | 0.140 |
Why?
| | Male | 13 | 2025 | 67762 | 0.140 |
Why?
| | Antigens, Neoplasm | 1 | 2020 | 319 | 0.140 |
Why?
| | Specimen Handling | 1 | 2019 | 183 | 0.140 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 156 | 0.130 |
Why?
| | Histones | 1 | 2022 | 636 | 0.130 |
Why?
| | Brain | 3 | 2023 | 2668 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 622 | 0.120 |
Why?
| | Prostatic Neoplasms | 1 | 2023 | 1043 | 0.120 |
Why?
| | Alzheimer Disease | 1 | 2022 | 560 | 0.120 |
Why?
| | Survival Rate | 1 | 2020 | 1972 | 0.120 |
Why?
| | RNA | 1 | 2022 | 921 | 0.120 |
Why?
| | DNA Methylation | 1 | 2020 | 643 | 0.120 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1430 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1079 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2024 | 6079 | 0.110 |
Why?
| | Adolescent | 6 | 2025 | 21513 | 0.110 |
Why?
| | DNA-Binding Proteins | 1 | 2021 | 1502 | 0.110 |
Why?
| | Molecular Typing | 1 | 2013 | 22 | 0.100 |
Why?
| | Female | 10 | 2025 | 73304 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 760 | 0.100 |
Why?
| | Child | 6 | 2024 | 21935 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2020 | 855 | 0.100 |
Why?
| | Escherichia coli Infections | 1 | 2013 | 111 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4030 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 1 | 2013 | 186 | 0.090 |
Why?
| | Adult | 7 | 2024 | 37929 | 0.090 |
Why?
| | Astrocytes | 2 | 2023 | 210 | 0.090 |
Why?
| | Child, Preschool | 3 | 2024 | 11074 | 0.090 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 674 | 0.080 |
Why?
| | Microglia | 2 | 2022 | 251 | 0.080 |
Why?
| | Mice | 5 | 2025 | 17787 | 0.080 |
Why?
| | Escherichia coli | 1 | 2013 | 815 | 0.080 |
Why?
| | Neoplasms | 1 | 2022 | 2671 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2025 | 3412 | 0.060 |
Why?
| | Paracrine Communication | 1 | 2025 | 65 | 0.060 |
Why?
| | Vagus Nerve | 1 | 2025 | 86 | 0.060 |
Why?
| | Middle Aged | 6 | 2024 | 33479 | 0.060 |
Why?
| | Angiomyolipoma | 1 | 2024 | 24 | 0.060 |
Why?
| | Eye Neoplasms | 1 | 2024 | 18 | 0.060 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2024 | 35 | 0.060 |
Why?
| | Animals | 5 | 2025 | 36940 | 0.050 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2025 | 198 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 59 | 0.050 |
Why?
| | Infant | 3 | 2025 | 9465 | 0.050 |
Why?
| | Anal Canal | 1 | 2024 | 97 | 0.050 |
Why?
| | Glutamic Acid | 1 | 2025 | 246 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2024 | 191 | 0.050 |
Why?
| | beta Catenin | 1 | 2025 | 253 | 0.050 |
Why?
| | Microscopy | 1 | 2024 | 152 | 0.050 |
Why?
| | Endothelium | 1 | 2022 | 123 | 0.050 |
Why?
| | Spectrum Analysis, Raman | 1 | 2022 | 41 | 0.050 |
Why?
| | Neuroglia | 1 | 2023 | 173 | 0.050 |
Why?
| | Pericytes | 1 | 2022 | 34 | 0.050 |
Why?
| | Synapses | 1 | 2025 | 427 | 0.050 |
Why?
| | California | 1 | 2022 | 431 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 594 | 0.040 |
Why?
| | Myelin Sheath | 1 | 2022 | 167 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 13209 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1129 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2024 | 506 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 617 | 0.040 |
Why?
| | Aged | 4 | 2024 | 23961 | 0.040 |
Why?
| | Gallbladder | 1 | 2019 | 19 | 0.040 |
Why?
| | Cholelithiasis | 1 | 2019 | 38 | 0.040 |
Why?
| | Hemodilution | 1 | 2019 | 10 | 0.040 |
Why?
| | Choledocholithiasis | 1 | 2019 | 19 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2024 | 15657 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2024 | 712 | 0.040 |
Why?
| | Cholecystectomy | 1 | 2019 | 62 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2022 | 433 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2019 | 189 | 0.040 |
Why?
| | Ecosystem | 1 | 2023 | 596 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2025 | 2475 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2757 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7635 | 0.030 |
Why?
| | Bone Marrow | 1 | 2019 | 286 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2022 | 785 | 0.030 |
Why?
| | Lymphocytes | 1 | 2019 | 397 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2022 | 847 | 0.030 |
Why?
| | Hippocampus | 1 | 2022 | 895 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1483 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1060 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1719 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 10811 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1946 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2833 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2023 | 1991 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1431 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3196 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1774 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1996 | 0.030 |
Why?
| | Germany | 1 | 2013 | 121 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1793 | 0.020 |
Why?
| | Lung | 1 | 2025 | 4060 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2013 | 200 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2019 | 938 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 812 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1809 | 0.010 |
Why?
| | United States | 1 | 2013 | 14841 | 0.010 |
Why?
|
|
Toland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|